Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment

Clinical trial NCT00458744 · WITHDRAWN

Trial details

NCT number: NCT00458744
Sponsor: Children's Oncology Group
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors Leukemia Lymphoma Unspecified Childhood Solid Tumor, Protocol Specific

Start date: 2007-02-01
Primary completion: 2008-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.